Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,895 | 169 | 98.9% |
| Education | $21.25 | 7 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $291.44 | 52 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $272.19 | 10 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $217.76 | 19 | $0 (2018) |
| Amgen Inc. | $196.20 | 14 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $170.12 | 16 | $0 (2018) |
| Lilly USA, LLC | $131.45 | 12 | $0 (2018) |
| Novo Nordisk Inc | $105.07 | 8 | $0 (2023) |
| GlaxoSmithKline, LLC. | $80.44 | 6 | $0 (2018) |
| Allergan Inc. | $75.71 | 5 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $58.86 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $14.91 | 1 | Novo Nordisk Inc ($14.91) |
| 2021 | $13.33 | 1 | AbbVie Inc. ($13.33) |
| 2018 | $567.17 | 52 | PFIZER INC. ($110.49) |
| 2017 | $1,321 | 122 | AstraZeneca Pharmaceuticals LP ($234.91) |
All Payment Transactions
176 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.91 | General |
| 10/15/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Endocrinology | ||||||
| 06/22/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: DIABETES | ||||||
| 06/21/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/15/2018 | Regeneron Healthcare Solutions, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/14/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: RESPIRATORY | ||||||
| 06/07/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/06/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/06/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/04/2018 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 06/01/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: DIABETES | ||||||
| 05/31/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), ASMANEX, BELSOMRA | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/31/2018 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: VACCINES | ||||||
| 05/24/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/21/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: DIABETES | ||||||
| 05/17/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: RESPIRATORY | ||||||
| 05/16/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Endocrinology | ||||||
| 05/09/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI, STIOLTO RESPIMAT | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: DIABETES | ||||||
| 05/04/2018 | AbbVie, Inc. | Androgel (Drug), Synthroid | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Endocrinology | ||||||
| 05/02/2018 | Ironwood Pharmaceuticals, Inc | LINZESS (Drug), VIBERZI, DUZALLO | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Gastroenterology | ||||||
| 04/30/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Diabetes | ||||||
| 04/27/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: DERMATOLOGY | ||||||
| 04/27/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $1.14 | General |
| Category: DERMATOLOGY | ||||||
| 04/19/2018 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $1.08 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 720 | 883 | $305,025 | $77,559 |
| 2022 | 10 | 667 | 781 | $261,544 | $66,919 |
| 2021 | 16 | 813 | 957 | $310,108 | $80,523 |
| 2020 | 14 | 827 | 998 | $242,822 | $70,244 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 222 | 347 | $129,742 | $26,986 | 20.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 182 | 182 | $69,542 | $22,793 | 32.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 58 | 73 | $38,573 | $8,398 | 21.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 18 | 21 | $17,112 | $4,511 | 26.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 57 | 57 | $8,835 | $4,321 | 48.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 71 | $18,718 | $3,844 | 20.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 22 | 25 | $15,113 | $3,679 | 24.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 66 | 66 | $3,900 | $1,944 | 49.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 14 | $2,172 | $554.19 | 25.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $720.00 | $382.85 | 53.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 14 | $598.00 | $145.47 | 24.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 178 | 178 | $68,442 | $22,652 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 191 | 269 | $98,674 | $20,409 | 20.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 66 | 84 | $44,547 | $10,058 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 76 | $19,714 | $4,554 | 23.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 46 | 46 | $8,964 | $3,140 | 35.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 13 | 14 | $11,423 | $2,807 | 24.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 56 | 57 | $2,850 | $1,615 | 56.7% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 25 | 25 | $3,750 | $935.50 | 24.9% |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | Office | 2022 | 17 | 17 | $2,550 | $602.90 | 23.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 15 | $630.00 | $146.11 | 23.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 212 | 331 | $122,470 | $25,867 | 21.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 168 | 168 | $63,672 | $21,915 | 34.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 55 | 67 | $34,706 | $8,856 | 25.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 54 | 56 | $10,248 | $3,646 | 35.6% |
About Dr. John Streiff, MD
Dr. John Streiff, MD is a Family Medicine healthcare provider based in Edinboro, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689652786.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Streiff, MD has received a total of $1,916 in payments from pharmaceutical and medical device companies, with $14.91 received in 2023. These payments were reported across 176 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,895).
As a Medicare-enrolled provider, Streiff has provided services to 3,027 Medicare beneficiaries, totaling 3,619 services with total Medicare billing of $295,245. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Edinboro, PA
- Active Since 01/09/2006
- Last Updated 10/07/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1689652786
Products in Payments
- Prolia (Biological) $196.20
- JARDIANCE (Drug) $157.74
- JANUVIA (Drug) $116.75
- MOVANTIK (Drug) $110.76
- BEVESPI AEROSPHERE (Drug) $104.12
- CHANTIX (Drug) $75.42
- EUCRISA (Drug) $71.58
- LYRICA (Drug) $70.99
- SPIRIVA (Drug) $66.05
- TRULICITY (Drug) $63.61
- TRADJENTA (Drug) $56.70
- LINZESS (Drug) $56.64
- XARELTO (Drug) $50.79
- TOUJEO (Drug) $48.21
- PREVNAR - 13 (Biological) $42.55
- Victoza (Drug) $38.92
- MYDAYIS (Drug) $38.27
- FARXIGA (Drug) $38.22
- BREO (Drug) $35.87
- TRELEGY ELLIPTA (Drug) $33.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Edinboro
William Getson, Md, MD
Family Medicine — Payments: $3,122
Travis Bishop, Do, DO
Family Medicine — Payments: $2,391
Maggie Biebel, D.o, D.O
Family Medicine — Payments: $1,111
Randy Edwards, D.o, D.O
Family Medicine — Payments: $578.76
Julie Wehrer, Md, MD
Family Medicine — Payments: $31.42
Jeffrey Caldwell
Family Medicine